Themis Medicare Limited
NSE:THEMISMED.NS
263.45 (INR) • At close November 1, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Themis Medicare Limited |
Symbool | THEMISMED.NS |
Munteenheid | INR |
Prijs | 263.45 |
Beurswaarde | 24,247,964,345 |
Dividendpercentage | 0.24% |
52-weken bereik | 142 - 303 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Dr. Sachin Dinesh Patel CChem., Ph.D. |
Website | https://www.themismedicare.com |
An error occurred while fetching data.
Over Themis Medicare Limited
Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients and formulations for use in various therapeutic areas, including anti-infective, antimalarial, anti-tuberculosis, cardiology, health and nutrition, oncology, ophthalmology, and pain management. The company was formerly known as Themis Chemicals
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)